RIKEN Brain Science Institute (RIKEN BSI) RIKEN BSI News No. 19 (Feb. 2003)




Approaching the Mystery of Neuronal Death

Dr. Ryosuke Takahashi
Head, Laboratory for
Motor System
Neurodegeneration


IMAGE
magnified scene by clicking image
Fig.1
The primary research focuses of our lab are the etiology and development of treatments for amyotrophic lateral sclerosis (ALS) and Parkinson's disease. With ALS, the motor nerve cells degenerate, hindering muscle control, eventually causing death. In a few years, the body's voluntary movement including respiration (i.e. the respiratory system) start to breakdown, which limits the patient's freedom to move and breathe with the use of machines and supports. As the patient's dire situation compels physcians to do something for this disease. Parkinson's disease also impairs motor function; however, in this case, neurons called dopaminergic neurons which act on the central control of motion die causing motion to slow and frequent falling and stumbling. As the disease progress, the patient is bedridden. Parkinson's disease is relatively common disease, occurring in more than 1% of persons over 65. As developed societies age, this disease will be a more grave concern. In general, ALS and Parkinson's disease are non-hereditary, neurodegenerative diseases. Older textbooks use "neurodegenerative diseases" as a generic term for diseases that have unknown causes, gradually develop and progress with aging, and pathologically cause degenerative loss of neurons or fibers in the nervous system (partial modification of the definition by Dr. Nobuo Yanagisawa). In short, these are strange, intractable diseases. Twenty years ago when I was senior medical student, I saw a video during a neurology lecture of a patient with a hereditary neurodegenerative disease, Huntington's disease. This disease is also called Huntington's chorea and one of its main symptoms is that the hands and feet move involuntarily as if they are dancing. After the lecture a friend, who later became an excellent surgeon, asked me, "Do you think such an intractable disease will ever be cured?" Knowing that I wanted to be a neurologist, I wistfully predicted, "The causes of neurodegenerative diseases will surely be elucidated and treatment methods will be developed." Looking back at the splendid research on neurodegenerative diseases over the last 20 years, my hunch was not far off. Rapid progress in research has been possible because of advanced in genetics; and, even though the causes of neurodegenerative diseases are still unknown, it is clear that the causes of hereditary diseases are genetic. When I graduated from college, the locus of Huntington's disease was determined, and since then most of the causative genes of major hereditary neurodegenerative diseases have been identified. Functional analyses of etiological genes based on these results followed, leading to two important discoveries. One was the discovery that many hereditary neurodegenerative diseases develop from the accumulation of abnormal proteins caused by gene mutations (Fig. 1).
IMAGE
magnified scene by clicking image
Fig.2

IMAGE
magnified scene by clicking image
Fig.3
Accurate protein folding is essential to permit them to function normally. Therefore, misfolded proteins do not function properly, adhere to one another, agglutinate, precipitate inside and outside the cells, and exhibit cytotoxicity. Another discovery was that the gene products (proteins) causing hereditary diseases often cause similar non-hereditary diseases, too. Parkinson's disease is a good example. -synuclein was first identified as the etiologic gene causing autosomal-dominant hereditary Parkinson's disease, which is very rare-occurring in only a few families in the world. And yet identification of the gene in this disease has greatly benefited research on the more common, non-hereditary Parkinson's disease. After identifying the gene, the main component of an abnormal aggregate in the neuron, the Lewy body (which pathologically characterizes Parkinson's disease) was confirmed to be -synuclein. It is now widely accepted that -synuclein, the protein misfolded by hereditary or acquired factors, causes Parkinson's disease by exhibiting neurotoxicity. Our team is focusing on two proteins, mutant SOD1 (which is the etiology of autosomal-dominant hereditary ALS) and Parkin (which is deficient in autosomal-recessive hereditary Parkinson's disease (AR-JP)). So far, we have confirmed that mutant SOD1 exhibits the characteristics of a misfolded protein and these characteristics worsen with oxidative stress (Fig. 2). We have also discovered that Parkin is the enzyme participating in proteolysis and believe that the misfolded protein, Pael receptor, accumulates due to lack of Parkin, causing AR-JP (Fig. 3). Since the Pael receptor may participate in the etiology of non-hereditary Parkinson's disease by locating downstream the signal for neuronal death caused by -synuclein, we are trying to clarify the route. We are also working to find the pathologic signals related to neurodegeneration. We have succeeded in isolating a new inducer for neuronal death named HtrA2 and are investigating its involvement in specific deseases. We will continue with this research to develop treatments for ALS and Parkinson's disease as soon as possible. Six years ago the accumulation of polyglutamine, a misfolded protein was identified as the cause of Huntington's disease. And recent studies using animal models have demonstrated the effects of this disease are alleviated by a molecule chaperone, a transcriptional factor, inhibition of apoptosis, etc. Something believed impossible by my classmate more than 20 years ago, the treatment of neurodegenerative diseases, is no longer a dream. Our team is striving to develop real treatments.

NEXT
RIKEN BSI NEWS

RIKEN BSI HOME
BACK
RIKEN Brain Science Institute (RIKEN BSI)
Copyright All Rights Reserved.